ELIGARD® Leuprolide Acetate 45 mg Injection

Name: Antineoplastic Agent
Brand: ELIGARD®

ELIGARD LEUPROLIDE ACETATE, SYR 45MG 6MO

McKesson #

1228047

Manufacturer #

62935046150

Brand

ELIGARD®

Manufacturer

Tolmar Pharmaceuticals

Country of Origin

Unknown

Alternate Manufacturer Number

2849735

Application

Antineoplastic Agent

Container Type

Single-Dose Kit

Dosage Form

Injection

Generic Drug Code

24301

Generic Drug Name

Leuprolide Acetate

NDC Number

62935046150

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements

Requires Refrigeration

Strength

45 mg

Type

Subcutaneous

UNSPSC Code

51111807

ELIGARD is an injectable suspension of leuprolide acetate available in a pre-connected syringe system and packaged with a sterile safety needle and cap, a desiccant, prescribing information and instructions for use
The pre-connected syringe system consists of syringe A and syringe B connected using a coupling device Syringe A contains the in situ polymeric extended release technology and the syringe B contains leuprolide acetate powder
When reconstituted, ELIGARD is administered as a single dose
Extended Release